These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23233848)

  • 21. Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction?
    Gundlach AL
    Eur J Pharmacol; 2002 Apr; 440(2-3):255-68. PubMed ID: 12007540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galanin/GALP receptors and CNS homeostatic processes.
    Robinson JK; Bartfai T; Langel U
    CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):327-34. PubMed ID: 16787232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Galanin-like peptide (GALP): localization, receptors and biological function].
    Wodowska J; Ciosek J
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():1067-76. PubMed ID: 26400892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galanin receptors as a potential target for neurological disease.
    Freimann K; Kurrikoff K; Langel Ü
    Expert Opin Ther Targets; 2015; 19(12):1665-76. PubMed ID: 26220265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel galanin receptor subtype specific ligands in feeding regulation.
    Saar I; Runesson J; McNamara I; Järv J; Robinson JK; Langel U
    Neurochem Int; 2011 May; 58(6):714-20. PubMed ID: 21333705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors.
    Xu ZQ; Shi TJ; Hökfelt T
    J Comp Neurol; 1998 Mar; 392(2):227-51. PubMed ID: 9512271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Galanin a Promising Therapeutic Resource for Neural and Nonneural Diseases?
    Oliveira Volpe CM; Vaz T; Rocha-Silva F; Villar-Delfino PH; Nogueira-Machado JA
    Curr Drug Targets; 2020; 21(9):922-929. PubMed ID: 32096740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin.
    Wang S; Clemmons A; Strader C; Bayne M
    Biochemistry; 1998 Jun; 37(26):9528-35. PubMed ID: 9649336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of intrathecal galanin message-associated peptide (GMAP) on the flexor reflex in rats.
    Xu XJ; Andell S; Hao JX; Wiesenfeld-Hallin Z; Bartfai T
    Regul Pept; 1995 Jul; 58(1-2):19-24. PubMed ID: 8570856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and chromatographic analysis of galanin message-associated peptide (GMAP)-like immunoreactivity in the rat.
    Xu Y; Rökaeus A; Johansson O
    Regul Pept; 1994 Apr; 51(1):1-16. PubMed ID: 8036281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragments of galanin message-associated peptide (GMAP) modulate the spinal flexor reflex in rat.
    Xu XJ; Andell S; Bartfai T; Wiesenfeld-Hallin Z
    Eur J Pharmacol; 1996 Dec; 318(2-3):301-6. PubMed ID: 9016918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of galanin-like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor.
    Man PS; Lawrence CB
    J Neuroendocrinol; 2008 Jan; 20(1):128-37. PubMed ID: 18081561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the spinal degradation products and inhibition of adenylate cyclase by recombinant rat galanin message-associated peptide.
    Andell-Jonsson S; Bartfai T
    Neuropeptides; 1998 Apr; 32(2):191-6. PubMed ID: 9639260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the chicken galanin type I receptor (GalR1) and a novel GalR1-like receptor (GalR1-L).
    Ho JC; Kwok AH; Zhao D; Wang Y; Leung FC
    Gen Comp Endocrinol; 2011 Jan; 170(2):391-400. PubMed ID: 20977910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galanin receptor ligands.
    Lu X; Lundström L; Langel U; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):143-6. PubMed ID: 15944002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy.
    Corness J; Shi TJ; Xu ZQ; Brulet P; Hökfelt T
    Exp Brain Res; 1996 Nov; 112(1):79-88. PubMed ID: 8951409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
    Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
    Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificity.
    Church WB; Jones KA; Kuiper DA; Shine J; Iismaa TP
    Protein Eng; 2002 Apr; 15(4):313-23. PubMed ID: 11983932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galanin, galanin receptors, and drug targets.
    Mitsukawa K; Lu X; Bartfai T
    Exp Suppl; 2010; 102():7-23. PubMed ID: 21299058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity.
    Page AJ; Slattery JA; Brierley SM; Jacoby AS; Blackshaw LA
    J Physiol; 2007 Sep; 583(Pt 2):675-84. PubMed ID: 17627995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.